Skip to main content

Selumetinib Sulfate

Placeholder slot
 (SEL-yoo-MEH-tih-nib SUL-fayt)

This page contains brief information about selumetinib sulfate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Koselugo
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Selumetinib sulfate is approved to treat:

Selumetinib sulfate is also being studied in the treatment of other types of cancer.

More About Selumetinib Sulfate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Selumetinib Sulfate - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Selumetinib Approved by FDA to Treat Children with NF1

In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

Selumetinib Continues to Show Promise in Children with NF1

Clinical Trials Accepting Patients

Find Clinical Trials for Selumetinib Sulfate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: